A4I News

News

Posted 28/05/2020

Sixfold expands its portfolio of collaborative projects

Sixfold Bioscience, a biotechnology company focused on the development of drug delivery systems for gene therapeutics, has been awarded a third grant through the ‘Analysis for Innovators’ (A4I) programme co-funded by the UK’s innovation agency — Innovate UK. The project will expand the capabilities of Sixfold’s proprietary delivery systems.
Read more
Analysis for Innovators
NPL NEL NML